SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Morepen Laboratories incorporates step-down subsidiary

20 Mar 2025 Evaluate

Morepen Laboratories has received approval from Ministry of Corporate Affairs for incorporation of step-down subsidiary -- Quick Med. The subsidiary has been incorporated on March 20, 2025. Quick Med is a subsidiary of Dr. Morepen, a fully-owned subsidiary of Morepen Laboratories.

Recently, Dr. Morepen (DML) had received approval from Board of Directors for the formation of a new subsidiary company on February 19, 2025.  

Morepen Laboratories is engaged in the manufacturing and sale of APis/ Bulk Drugs, Home Diagnostics, Formulations and OTC products. 


Morepen Laboratories Share Price

48.31 -1.06 (-2.15%)
11-Jun-2026 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.10
Dr. Reddys Lab 1281.50
Cipla 1386.10
Zydus Lifesciences 1101.70
Lupin 2272.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: